Publikationen, an denen er mitarbeitet JUAN FRANCISCO ASCASO GIMILIO (121)

2020

  1. Chronic kidney disease as a cardiovascular risk factor

    Journal of hypertension, Vol. 38, Núm. 11, pp. 2110-2121

2019

  1. Gene expression profile following an oral unsaturated fat load in abdominal obese subjects

    European Journal of Nutrition, Vol. 58, Núm. 3, pp. 1331-1337

2018

  1. Correction: Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study (PLoS ONE (2017) 12:10 (e0186196) DOI: 10.1371/journal.pone.0186196)

    PLoS ONE

  2. LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study

    International Journal of Cardiology, Vol. 264, pp. 172-178

  3. PAI-1 levels are related to insulin resistance and carotid atherosclerosis in subjects with familial combined hyperlipidemia

    Journal of Investigative Medicine, Vol. 66, Núm. 1, pp. 17-21

2017

  1. Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study

    PLoS ONE, Vol. 12, Núm. 10

2016

  1. Increased thioredoxin levels are related to insulin resistance in familial combined hyperlipidaemia

    European Journal of Clinical Investigation, Vol. 46, Núm. 7, pp. 636-642

  2. Unsaturated oral fat load test improves glycemia, insulinemia and oxidative stress status in nondiabetic subjects with abdominal obesity

    PLoS ONE, Vol. 11, Núm. 8

2015

  1. Importancia de la dislipidemia en la enfermedad cardiovascular: Un punto de vista

    Clinica e Investigacion en Arteriosclerosis, Vol. 27, Núm. 6, pp. 301-308

  2. Importancia de la dislipidemia en la enfermedad cardiovascular: un punto de vista

    Clínica e investigación en arteriosclerosis, Vol. 27, Núm. 6, pp. 301-308

2014

  1. Enhanced reduction in oxidative stress and altered glutathione and thioredoxin system response to unsaturated fatty acid load in familial hypercholesterolemia

    Clinical Biochemistry, Vol. 47, Núm. 18, pp. 291-297

  2. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study

    Clínica e investigación en arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114

  3. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study

    Clinica e Investigacion en Arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114

2013

  1. Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population

    International Journal of Clinical Practice, Vol. 67, Núm. 1, pp. 81-88

  2. Oxidative stress and antioxidant enzyme values in lymphomonocytes after an oral unsaturated fat load test in familial hypercholesterolemic subjects

    Translational Research, Vol. 161, Núm. 1, pp. 50-56

2012

  1. AT1 receptor gene polymorphisms in relation to postprandial lipemia

    International Journal of Vascular Medicine, Vol. 2012

  2. Grosor íntima-media carotídeo y frecuencia de placas de ateroma en población española sin factores de riesgo cardiovascular

    Clínica e investigación en arteriosclerosis, Vol. 24, Núm. 4, pp. 181-187

  3. Grosor íntima-media carotídeo y frecuencia de placas de ateroma en población española sin factores de riesgo cardiovascular

    Clinica e Investigacion en Arteriosclerosis, Vol. 24, Núm. 4, pp. 181-187

  4. Plasma homocysteine levels are independently associated with the severity of peripheral polyneuropathy in type 2 diabetic subjects

    Journal of the Peripheral Nervous System, Vol. 17, Núm. 2, pp. 191-196

2011

  1. Miocardiopatía catecolamínica desencadenada por un feocromocitoma

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 58, Núm. 4, pp. 204-206